More on REVB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)

Upcoming Events

- Earnings (8/7/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Revelation Biosciences (NQ:REVB)
Delayed: 1.00 -0.01 (0.99%)
Prev. Close $1.01  
Open$1.03 
52 Wk High$16.00 
52 Wk Low$10.65 
Day High$1.03 
Day Low$1.00 
P/E N/A  
EPS$0.00 
Volume36,220 


Jun 1, 2026 05:27 PM Form 8-K REVELATION BIOSCIENCES, For: Jun 01
Jun 1, 2026 09:00 AM Revelation Biosciences adds two experts to kidney injury advisory board
Jun 1, 2026 09:00 AM Revelation Biosciences Expands Acute Kidney Injury Advisory Board
May 15, 2026 11:35 AM Form SCHEDULE 13G REVELATION BIOSCIENCES, Filed by: ARMISTICE CAPITAL, LLC
May 11, 2026 09:57 AM Form DEF 14A REVELATION BIOSCIENCES, For: Jun 24
May 11, 2026 09:02 AM Revelation Biosciences plans Phase 2/3 study for kidney injury drug
May 11, 2026 09:00 AM Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders
May 11, 2026 08:45 AM Form ARS REVELATION BIOSCIENCES, For: May 11
May 7, 2026 04:27 PM Form 8-K REVELATION BIOSCIENCES, For: May 07
May 7, 2026 04:17 PM Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026
View All Articles

Entities mentioned with REVB

View All Entities